蘇錦松
個(gè)人簡(jiǎn)介
蘇錦松，博士，副教授，碩士研究生導(dǎo)師，研究方向?yàn)橹兴幖懊褡逅幍乃幮镔|(zhì)基礎(chǔ)及作用機(jī)制研究。主持7項(xiàng)科研課題，國(guó)家自然科學(xué)基金1項(xiàng)，省部級(jí)項(xiàng)目2項(xiàng)，參與國(guó)家重點(diǎn)研發(fā)計(jì)劃項(xiàng)目1項(xiàng)，國(guó)家自然科學(xué)基金重點(diǎn)項(xiàng)目1項(xiàng)，發(fā)表論文25篇，其中SCI論文15篇，授權(quán)專利1項(xiàng)。四川省中醫(yī)藥適宜技術(shù)研究會(huì)民族醫(yī)藥分會(huì)副秘書長(zhǎng)，中國(guó)博士后科學(xué)基金會(huì)科技扶貧青年指導(dǎo)專家。
E-mail：sujinsong@cdutcm.edu.cn
代表性成果（可含承擔(dān)項(xiàng)目、發(fā)表論文、論著、獲獎(jiǎng)等）
承擔(dān)項(xiàng)目（主持）
1.基于NLRP3-細(xì)胞焦亡的藏藥漆賽爾桑當(dāng)松湯“異病同治”效應(yīng)物質(zhì)及作用機(jī)制研究，82204765，國(guó)家自然科學(xué)基金青年項(xiàng)目，2023-01至2025-12，30萬元
2.基于NLRP3-細(xì)胞焦亡通路的藏藥黃葵子抗抗RA效應(yīng)物質(zhì)及作用機(jī)制研究，TB2023020，四川省博士后特別資助項(xiàng)目，2023-01至2024-06，10萬元
3.基于JAK-STA信號(hào)通路的藏藥黃葵子抗RA藥效物質(zhì)及作用機(jī)制研究，2022NSFSC1470，四川省科技廳面上項(xiàng)目，2023-01至2024-06，10萬元
4.獨(dú)活寄生湯的配方顆粒與傳統(tǒng)湯劑抗類風(fēng)濕關(guān)節(jié)炎的一致性評(píng)價(jià)，2021ZYY013，宜賓市科技局，2023-06至2024-09，4萬元
5.藏藥黃葵子“干黃水”抗特應(yīng)性皮炎藥效物質(zhì)基礎(chǔ)及作用機(jī)制研究，BSH2020032，成都中醫(yī)藥大學(xué)，2021-07至2024-07，12萬元
6.彝族藥兩頭毛的化學(xué)成分研究，成都菲奧諾克生物科技有限公司，2023-12至2025-12，10萬元
發(fā)表論文（標(biāo)記#為第一作者；標(biāo)記*為通訊作者）
1. Yiwen Tao, Jia Liu, Mengjia Li, Hongling Wang, Gang Fan, Xiaolong Xie, Xing Fu, Jinsong Su*, Abelmoschus manihot (L.) medik. seeds alleviate rheumatoid arthritis by modulating JAK2/STAT3 signaling pathway, Journal of Ethnopharmacology, 2024, 325, 117641.
2. Tianru Wang, Qiuyue Li, Ziyu Zhou, Jia Liu, Yiwen Tao, Yi Zhang, Yong Zeng, Sanyin Zhang, Jinsong Su*, Review of traditional uses, phytochemistry and pharmacology of Tibetan Medicine tangchong, Journal of Ethnopharmacology, 2024, 319, 117129.
3. Jing Ma, Qiuyue Li, Ting Wang, Hanyu Lu, Jia Liu, Rangji Cai, Yi Zhang, Jing Zhang, Xiaolong Xie, Jinsong Su*, A comprehensive review of Shengdeng in Tibetan medicine: textual research, herbal and botanical distribution, traditional uses, phytochemistry, and pharmacology, Frontiers in pharmacology, 2024, 14, 1303902.
4. Jinsong Su#, Yiwen Tao, Jia Liu , Jiayi Sun, Yong Zeng, Xianli Meng, Gang Fan, Yi Zhang, Tibetan medicine Qi-Sai-Er-Sang-Dang-Song Decoction inhibits TNF-α-induced rheumatoid arthritis in human fibroblast-like synoviocytes via regulating NOTCH1/NF-κB/NLRP3 pathway, Journal of Ethnopharmacology, 2023, 310, 116402.
5. Jia Liu, Yiwen Tao, Xuemei Zou, Qian Liu, Xianli Meng, Yi Zhang, Jinsong Su*, In vitro and in vivo exploration of the anti-atopic dermatitis mechanism of action of Tibetan medicine Qi-Sai-Er-Sang-Dang-Song decoction, Journal of Ethnopharmacology, 2023, 306, 116155.
6. JianRong Luo, Jia Liu, TingShun Luo, Heng Liu, JinSong Su*, Yi Zhang, Blapsimidazolium A: A new imidazolium carboxylate derivative with anti-inflammatory activity from medicinal insect Blaps rynchopetera, Fitoterapia, 2023, 164, 105386.
7. Jinsong Su#, Fujing Yang, Xuemei Kang, Jia Liu, Yiwen Tao, Qingchun Diao, Xianli Meng, Deming Liu, Yi Zhang, Chalcone derivatives from abelmoschus manihot seeds restrain NLRP3 inflammasome assembly by inhibiting ASC oligomerization, Frontiers in Pharmacology, 2022, 13, 932198.
8. Yi Zhu, Na Xie, Yilu Chai, Yisen Nie, Ke Liu, Yufei Liu, Yang Yang, Jinsong Su*, Chuantao Zhang, Apoptosis Induction, a Sharp Edge of Berberine to Exert Anti-Cancer Effects, Focus on Breast, Lung, and Liver Cancer, Frontiers in Pharmacology, 2022, 13, 803717.
9. Jinsong Su#, Qiuyue Li, Jia Liu, Hongling Wang, Xuanhao Li, Dhondrup Wüntrang, Chuan Liu, Qian Zhao, Ruyu Yao, Xianli Meng, Yi Zhang, Ethyl acetate extract of tibetan medicine rhamnella gilgitica ameliorated type II collagen-induced arthritis in rats via regulating jak-stat signaling pathway, Journal of Ethnopharmacology, 2021, 276, 113514.
10. Jinsong Su#, Fuying Qin, Ying Liu, Yi Zhang, Four new polyynes from Codonopsis pilosula collected in Yunnan province, China, Natural Product Research, 2021, 35(21), 3548-3555.
專利
(1) 蘇錦松，張藝. 一種查爾酮類化合物及其制備方法和用途. 專利號(hào)：ZL 2022 1 0049775.2，授權(quán)公告號(hào)：CN 114315772 B